期刊文献+

国产可生物降解涂层支架治疗冠心病的临床研究 被引量:6

Clinical evaluation of domestic biodegradable drug-eluting stents in the treatment of coronary heart disease
暂未订购
导出
摘要 目的研究EXCEL支架临床应用的安全性和有效性。方法2008年1-10月,选择100例冠心病行PCI术并同意术后冠脉造影复查的患者,分为EXCEL组58例,Cypher组42例。观察介入治疗手术即刻成功率和住院期不良事件发生率,术后随访以及冠脉造影复查结果。结果两组患者基本情况以及冠状动脉病变支数、类型、置入支架平均长度方面差异无统计学意义,随访结果两组主要心脏不良事件(MACE)、支架内再狭窄和血栓发生率差异无统计学意义。结论与Cypher支架相比EXCEL支架MACE和支架内再狭窄率相似,均较低。 Objective To evaluate the safety and efficacy of domestic biodegradable drug-eluting stent, EXCEL, in clinical treatment of coronary heart disease. Methods During the period of Jan. 2008-Oct. 2008, 100 patients with coronary heart disease who consented to PCI and postoperative coronary angiography were selected and enrolled in the study. The patients were divided into EXCEL group (n = 58) and Cypher group (n = 42). The immediate successful rate of interventional therapy and the complications occurred during hospitalization were observed. Postoperative follow-up and checkup coronary angiography were conducted. Results No significant difference in the relevant clinical data, in the number and type of diseased coronary branch and in the mean length of implanted stents existed between two groups. Also, no statistically significant difference in the occurrence of major adverse cardiac event (MACE), in-stent restenosis and thrombosis was present between two groups. Conclusion Compared with Cypher stenting, EXCEL stenting carries similar, i.e. rather low, occurrence of MACE and in-stent restenosis.
出处 《介入放射学杂志》 CSCD 北大核心 2009年第7期534-536,共3页 Journal of Interventional Radiology
关键词 经皮冠脉介入治疗 生物可降解涂层药物支架 雷帕霉素 percutaneous coronary intervention biodegradable drug-eluting stent rapamycin
  • 相关文献

参考文献9

  • 1Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stem for coronary revascularization[J].N Engl J Med,2002,346:1773-1780.
  • 2Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in native coronary artery[J].N Engl J Med,2003,349:1315-1323.
  • 3Pache J,Dibra A,Mehilli J,et al.Drug eluting stents compared with thin-strut bare stents for the reduction of restenosis:a prospec tire,randomized trial[J].Eur Heart J,2005,26:1262-1268.
  • 4Takahashi S,Kaneda H,Tanaka S,et al.Late gngiographic stent thrombisis after Sirolimus-Eluting stent implantation[J].Cir J,2007,71:226-228.
  • 5Smith SC Jr,Dove JT,Jacobs AK,et al.ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percu-taneou trans luminal coronary angioplasty)[J].J Am Coll Cardiol,2001,37:2215-2239.
  • 6Mckeage K,Murdoch D,Goa KL.The sirolimus-eluting stent:a review of its use in the treatment of coronary artery disease[J].Am J Cardiovasc Drugs,2003,3:211-230.
  • 7Sino-SIRIUS研究组.国人应用雷帕霉素药物洗脱支架预防再狭窄的初步经验——Sino-SIRIUS临床试验[J].中华心血管病杂志,2003,31(11):814-817. 被引量:32
  • 8韩雅玲,荆全民,陈学智,王守力,马颖艳,刘海伟,栾波,王耿,李毅,王祖禄,王冬梅.国产生物降解涂层雷帕霉素洗脱支架置入术治疗冠心病一年结果:国内首项单中心注册研究[J].中国循环杂志,2008,23(1):5-9. 被引量:31
  • 9张玉霄,卢才义,薛桥,刘鹏,颜伟,吴兴利,陈瑞.载雷帕霉素可降解聚合物涂层支架治疗冠心病的临床观察[J].中华心血管病杂志,2006,34(11):971-974. 被引量:19

二级参考文献18

  • 1张玉霄,卢才义,薛桥,刘鹏,颜伟,吴兴利,陈瑞.载雷帕霉素可降解聚合物涂层支架治疗冠心病的临床观察[J].中华心血管病杂志,2006,34(11):971-974. 被引量:19
  • 2LIU Hai-bo XU Bo QIAO Shu-bin YANG Yue-jin MA Wei-hua QIN Xue-wen YAO Min WU Yong-jian YUAN Jin-qing CHEN Jue YOU Shi-jie DAI Jun XIA Ran LI Jian-jun CHEN Ji-lin GAO Run-lin.A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a “real world” setting:six-month follow-up results[J].Chinese Medical Journal,2007(7):574-577. 被引量:15
  • 3Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis : a volumetric intravascular ultrasound analysis. J Am Coll Cardiol, 1995, 26:720-724.
  • 4Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-slenl reslenosis. A serial intravascular ultrasound study. Circulation, 1996, 94: 1247-1254.
  • 5Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (ESIRIUS). Lancet, 2003, 362: 1093-1099.
  • 6Schampaert E, Cohen EA, Schluter M, et at. The Canadian study of the sirolimus-eluling stent in the treatment of patients with long denovo lesions in small native coronary arteries ( C-SIRIUS ). J Am Coll Cardiol, 2004, 43: 1110-1115.
  • 7Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" : the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.Circulation, 2004, 109: 190-195.
  • 8Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and threedimensional intravascular ultrasound study. Circulation, 2001, 103 :192-195.
  • 9Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluling stent with a standard stent for coronary revascularization. N Engl J Med, 2002, 346: 1773-1780.
  • 10Serruys PW, Degertekin M, Tanabe K, et al . Intravascular ultrasound findings in the multicenter, randomized , double-blind RAVEL (RAndomized study with the sirolimus-eluting Velocity balloon-expandable slenl in the treatment of patients with de novo native coronary, artery Lesions) trial. Circulation, 2002, 106: 798-803.

共引文献73

同被引文献43

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部